Alkermes (ALKS) Misses Q3 EPS by 3c; Lowers FY14 Profit Outlook
Tweet
Share
E-mailGet Alerts ALKS Hot Sheet
Price: $49.43 -1.69%
Financial Fact:
Interest expense: -2.17M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Interest expense: -2.17M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Alkermes (NASDAQ: ALKS) reported Q3 EPS of $0.11, $0.03 worse than the analyst estimate of $0.14. Revenue for the quarter came in at $153.4 million versus the consensus estimate of $146.91 million.
Alkermes sees FY2014 EPS of $0.19-$0.32, versus prior guidance of $0.41-$0.54 and the consensus of $0.49.
For earnings history and earnings-related data on Alkermes (ALKS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Omega Flex (OFLX) Tops Q2 EPS by 27c
- SuperCom (SPCB) Tops Q3 EPS by 43c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
